The news of a marked increase in adverse drug events reported to the FDA is sure to be one more arrow for those taking aim at "big pharma" and the FDA. The criticism is off target, however, because it fails to take into account the new ways drugs are being used.
From 1998 to 2005, the number of serious adverse effects from medicines reported to the FDA more than doubled, according to a report published in this week's Journal of the...
]]>